HomeCompareOVF vs JNJ

OVF vs JNJ: Dividend Comparison 2026

OVF yields 9.08% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OVF wins by $16.5K in total portfolio value
10 years
OVF
OVF
● Live price
9.08%
Share price
$29.22
Annual div
$2.65
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$36.5K
Annual income
$1,609.24
Full OVF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — OVF vs JNJ

📍 OVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOVFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OVF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OVF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OVF
Annual income on $10K today (after 15% tax)
$771.72/yr
After 10yr DRIP, annual income (after tax)
$1,367.85/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, OVF beats the other by $664.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OVF + JNJ for your $10,000?

OVF: 50%JNJ: 50%
100% JNJ50/50100% OVF
Portfolio after 10yr
$28.2K
Annual income
$1,218.51/yr
Blended yield
4.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OVF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OVF buys
0
JNJ buys
0
No recent congressional trades found for OVF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOVFJNJ
Forward yield9.08%3.36%
Annual dividend / share$2.65$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$36.5K$20.0K
Annual income after 10y$1,609.24$827.78
Total dividends collected$12.6K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OVF vs JNJ ($10,000, DRIP)

YearOVF PortfolioOVF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,608$907.91$10,676$355.77+$932.00OVF
2$13,405$984.94$11,407$389.39+$2.0KOVF
3$15,407$1,063.05$12,198$426.53+$3.2KOVF
4$17,627$1,141.83$13,056$467.62+$4.6KOVF
5$20,082$1,220.92$13,987$513.12+$6.1KOVF
6$22,788$1,299.96$14,998$563.56+$7.8KOVF
7$25,761$1,378.60$16,098$619.52+$9.7KOVF
8$29,021$1,456.55$17,295$681.69+$11.7KOVF
9$32,586$1,533.51$18,599$750.82+$14.0KOVF
10$36,477$1,609.24$20,022$827.78+$16.5KOVF

OVF vs JNJ: Complete Analysis 2026

OVFStock

The fund is an actively-managed exchange-traded fund ("ETF") that seeks to achieve its objective by (i) investing in one or more other ETFs that seek exposure to the performance of non-U.S. equity securities (from both developed and emerging markets) or directly in the securities held by such ETFs and (ii) selling and purchasing listed short-term put options to generate income to the fund.

Full OVF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this OVF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OVF vs SCHDOVF vs JEPIOVF vs OOVF vs KOOVF vs MAINOVF vs ABBVOVF vs MRKOVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.